ACTO and Philips Respironics Partnership Earns Nomination for the 2019 LTEN Excellence Award in Innovation

TORONTO, June 3, 2019 /CNW/ – ACTO and Philips Respironics’ partnership has earned a nomination for the 2019 LTEN Excellence Award in Innovation, honoring best-in-class learning and development initiatives within the life sciences. LTEN has recognized ACTO for their work with Philips Respironics in implementing the ACTO Commercialization Cloud. “In the past, training was a check-the-box event,” said Parth Khanna, CEO of ACTO, …

Our Customers

Our customersOur customers are at the heart of everything we do – we aim to not just deliver, but delight.Featured customer storiesPhilips Respironics increases sales by identifying top rep behavior on ACTOPhilips Respironics sought to understand and cultivate top rep behavior, while introducing a culture of continuous learning.Read the storyIdorsia improves product launch training and learning effectiveness with ACTO Idorsia …

Solutions – IT

Information TechnologyCL & DMedical AffairsCommercial ExcellenceITThe evolving needs inInformation Technology Simplify your tech stack Unify and consolidate learning into one omnichannel experience Integrate with ease Manage seamless user experience and workflows to keep adoption high Keep Learning Flexible Enable training to take place at any time, anyplace, in any way “ACTO combines Sales Training and Sales Enablement into one tool. …

ACTO Earns Gold at Brandon Hall Technology Awards 2021

Toronto, Ontario (December 15, 2021) –  ACTO, the creator of the innovative Omnichannel Education Platform for Life Sciences, today announced it won a coveted Brandon Hall Group Gold award for excellence in Best Advance in Learning Management Measurement/Business Impact Tools. The award is for Digitally Transforming the Life Sciences Industry with Omnichannel Education. ACTO’s technology uses AI-powered mobile experiences to …

ACTO Closes $11.5M Series A Round to Accelerate Virtual Transformation for Life Sciences Companies

TORONTO, Aug. 27, 2020 /PRNewswire/ – ACTO, the omnichannel education and engagement platform for life sciences, today announced the closing of a $11.5 million Series A round led by Resolve Growth Partners, a Baltimore-based growth equity firm focused on software entrepreneurs. The round also includes strategic funding from new investor Salesforce Ventures, as well as follow-on investment from existing investor Panache Ventures. ACTO is a …

ACTO Achieves 158% Year to Date Revenue Growth in 2019 and Has Digitally Transformed Over 50 Life Sciences Companies

TORONTO, Dec. 5, 2019 /CNW/ – ACTO achieved 158% year to date revenue growth and has digitally transformed over 50 life sciences companies, including global pharma, medical device, and dental companies. Since its launch one year ago, the ACTO Commercialization Cloud for Life Sciences has digitally transformed companies such as AstraZeneca, Teleflex, and Philips Respironics, enabling their field force to promote on …

eyeforpharma Awards Recognize Two ACTO Use Cases as Finalists

TORONTO, Nov. 25, 2019 /CNW/ – Two of ACTO’s use cases have been nominated as finalists in the eyeforpharma Awards, which focus on recognizing genuine, truly innovative and meaningful approaches to excellence in the pharmaceutical industry. AstraZeneca has been nominated in the ‘Most Promising MVP/Pilot’ category for its ACTO use case. ACTO has been nominated in the ‘Most Valuable Data & Insights …